Cutaneous T-Cell Lymphoma Refractory
4 clinical trials · Condition
◉ Watch Cutaneous T-Cell Lymphoma Refractory
| Record | Firm | Date |
|---|---|---|
| Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma (NCT04712864) | Legend Biotech USA Inc | 2021-09-13 |
Track Cutaneous T-Cell Lymphoma Refractory automatically
Every clearance here is in the API, with alerts when new ones post.